Sometimes athletes can be their own worst enemy especially when they continue to play following an injury to a foot or ankle. Surgeons presenting at the Annual Scientific Conference of the American College of Foot and Ankle Surgeons (ACFAS) are discussing athletic injuries and the importance of proper diagnosis, prompt treatment, and full healing and [...] Read more »

Dr. Angelo Malamis says that 90 percent of his patients who have undergone a treatment called balloon kyphoplasty for vertebral fractures report significant reductions in pain and disability. But the number of kyphoplasty referrals Malamis has received from primary care doctors has dropped sharply since two controversial studies were published last year in the [...] Read more »

Amgen Inc. (Nasdaq: AMGN) announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company’s Complete Response submission for Prolia(TM) (denosumab) in the treatment of postmenopausal osteoporosis and classified it as a Class 2 resubmission…

Read The Full Article…FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission And Targets Action Date Read more »

More than 850 abstracts have been received – guaranteeing broad global attendance at the year’s most noteworthy platform for osteoporosis research. Don’t miss the most important osteoporosis meeting of 2010, to be held in the center of Florence, Italy from May 5 to 8, 2010. Take advantage of lower rates: early bird registration rates still [...] Read more »

UroToday.com – Prostate cancer (CaP) patients often undergo a routine bone scan as part of their metastatic evaluation at the time of diagnosis. Most consensus recommendations suggest obtaining bone scans only in patients with risk characteristics suggesting reasonable utility for this test. However, according to a paper by Dr…

Read The Full Article…When To [...] Read more »

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA…

Read The Full Article…BioMimetic Therapeutics [...] Read more »

BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it has submitted the third and final module of its Premarket Approval (PMA) application for marketing of Augment™ Bone Graft in the U.S. This final module, containing a comprehensive review of the clinical data related to Augment, completes the PMA application to the FDA…

Read The Full Article…BioMimetic Therapeutics [...] Read more »

The results of a study of more than 4500 patients from six Italian EVEREST (European Vertebroplasty Research Team) Centers (Dr. G.C. Anselmetti-Candiolo Torino, Dr. G. Bonaldi-Bergamo, Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma, Dr. M…

Read The Full Article…Multi-Center Data In A Large Series Of Patients Show Vertebroplasty Provides Dramatic And Lasting Pain Relief For Vertebral Compression [...] Read more »

A “metal foam” that has a similar elasticity to bone could mean a new generation of biomedical implants that would avoid bone rejection that often results from more rigid implant materials, such as titanium…

Read The Full Article…New Material Mimics Bone To Create Better Biomedical Implants Read more »

Singapore meeting to feature top speakers, Meet-the-Expert Sessions, orthopaedic and diagnostic roundtables The International Osteoporosis Foundation (IOF) invites you to attend the IOF Regionals: 1st Asia-Pacific Osteoporosis Meeting to be held in Singapore from December 10 – 13, 2010. Visit http://www.iofbonehealth.org/singapore-2010 for complete information…

Read The Full Article…Don’t Miss The Opportunity To Attend The Most Exciting [...] Read more »